Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

41.03 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

February 05, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application

January 26, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) ↗

January 09, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

February 26, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years ↗

February 22, 2024

Via Benzinga

Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results

February 20, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today ↗

February 05, 2024

Via Benzinga

Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know ↗

January 30, 2024

Via Benzinga

Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 24, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues

January 08, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 05, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference

December 28, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 25, 2023

Via Benzinga

Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday ↗

December 22, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...

Via Benzinga

Topics Stocks

Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today? ↗

December 21, 2023

On Wednesday, Annexon Inc (NASDAQ: ANNX) reported results from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) healthy volunteer study of ANX1502 that targets the active form...

Via Benzinga

Micron Technology To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 15, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday? ↗

December 14, 2023

It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 14, 2023

Via Benzinga

Why Is Apellis Pharmaceuticals Stock Trading Lower Today? ↗

December 14, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) announced an update on the ongoing review of its marketing application for intravitreal pegcetacoplan for geographic atrophy (GA) secondary to age-related...

Via Benzinga

Apellis Crashes As Likely European Rejection Looms For Eye Drug Syfovre ↗

December 14, 2023

The treatment, Syfovre, has faced numerous safety concerns in the U.S., where it's approved.

Via Investor's Business Daily

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 14, 2023

Via Benzinga

Apellis Provides Update on Ongoing Regulatory Review of Pegcetacoplan for GA in the European Union

December 14, 2023

Conference call today at 8:30 a.m. ET

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 11, 2023

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...

Via Benzinga

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗

December 11, 2023

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.